In a recent study posted on Bio Rxiv*Preprint server, researchers evaluated the efficacy of a multivalent exosome-based coronavirus disease 2019 (COVID-19) vaccine. study: Exosome-Based Multivalent Vaccines:...
In a recent article published in Journal of Clinical Investigation, researchers collated findings on the evolution of primitive antigenic sin (OAS) and severe acute respiratory syndrome...
People with hematological malignancies are at increased risk of severe coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, few studies...
People suffering from blood cancers often have weak immune systems and are at increased risk of becoming seriously ill from COVID-19. Moreover, some cancer treatments result...
In two separate studies, researchers show how synthetic biology can be used to tackle the difficult problem of cancer immunotherapy. Immunotherapy-related approaches that focus on short-term...
Individuals infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) exhibit a wide range of clinical alterations, from asymptomatic infection to fatal disease. In a recent...
Recent Comments